Wellness influencers tout peptides for muscle repair, aging and immunity. Many of the synthetic ones being promoted have no FDA approval.
Recap by typeshit. Post by Facebook on Facebook.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Obesity doctor Spencer Nadolsky goes after misconceptions about the triple agonist still in trials. Tap through to see which claims he pushes back on.
A TriNetX study of 4,253 matched patients per group, shown at ACG 2026, found roughly half the MACE risk at one year with resmetirom. Retrospective data, so no causation.
Loading…